Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Four types of Tregs in malignant lymphomas
Jing Wang, Xiaoyan Ke
Journal of Hematology & Oncology (2011) Vol. 4, Iss. 1
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
Antonietta R. Farina, Andrew R. Mackay
Cancers (2014) Vol. 6, Iss. 1, pp. 240-296
Open Access | Times Cited: 186
Effects of tumor metabolic microenvironment on regulatory T cells
Yian Wang, Xiaoling Li, Yongzhen Mo, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 143
Novel CD20 monoclonal antibodies for lymphoma therapy
Shundong Cang, Nikhil Mukhi, Kemeng Wang, et al.
Journal of Hematology & Oncology (2012) Vol. 5, Iss. 1
Open Access | Times Cited: 131
Peripheral T cell lymphomas: from the bench to the clinic
Danilo Fiore, Luca Vincenzo Cappelli, Alessandro Broccoli, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 6, pp. 323-342
Closed Access | Times Cited: 105
The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients
Han Sol Choi, Sang Yun Ha, Hye‐Mi Kim, et al.
Oncotarget (2016) Vol. 7, Iss. 7, pp. 7940-7951
Open Access | Times Cited: 61
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver
Jan P. Nicolay, Jana D. Albrecht, Silvia Alberti Violetti, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1660-1671
Open Access | Times Cited: 42
Migration and homeostasis of regulatory T cells in rheumatoid arthritis
Konstantin Kotschenreuther, Shuaifeng Yan, David M. Kofler
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes
Yao‐Hui Huang, Yuran Qiu, Qunling Zhang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101416-101416
Open Access | Times Cited: 7
New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytes
Karen Bunting, Ari Melnick
Current Opinion in Immunology (2013) Vol. 25, Iss. 3, pp. 339-346
Open Access | Times Cited: 64
Epigenetics, autoimmunity and hematologic malignancies: A comprehensive review
Owen Ngalamika, Yiqun Zhang, Heng Yin, et al.
Journal of Autoimmunity (2012) Vol. 39, Iss. 4, pp. 451-465
Closed Access | Times Cited: 62
Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions
Farhad Jadidi‐Niaragh, Ghasem Ghalamfarsa, Mehdi Yousefi, et al.
Tumor Biology (2013) Vol. 34, Iss. 4, pp. 2031-2039
Closed Access | Times Cited: 55
Adult T-Cell Leukemia/Lymphoma
Sohail Qayyum, John Choi
Archives of Pathology & Laboratory Medicine (2014) Vol. 138, Iss. 2, pp. 282-286
Closed Access | Times Cited: 53
Association of Marek’s Disease induced immunosuppression with activation of a novel regulatory T cells in chickens
Angila Gurung, Nitin Machindra Kamble, Benedikt B. Kaufer, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 12, pp. e1006745-e1006745
Open Access | Times Cited: 53
Pathogenesis of Peripheral T Cell Lymphoma
Marco Pizzi, Elizabeth Margolskee, Giorgio Inghirami
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 293-320
Open Access | Times Cited: 47
Microenvironment Cell Contribution to Lymphoma Immunity
Deepika Kumar, Mina L. Xu
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 45
Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
Giovanni D’Arena, Candida Vitale, Marta Coscia, et al.
Journal of Immunology Research (2017) Vol. 2017, pp. 1-13
Open Access | Times Cited: 40
Demethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22
Yanyan Zhang, Yun Huang, Dianping Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4312-4328
Open Access | Times Cited: 4
Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma
Thomas Han, Ussama M. Abdel‐Motal, De-Kuan Chang, et al.
PLoS ONE (2012) Vol. 7, Iss. 9, pp. e44455-e44455
Open Access | Times Cited: 40
Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration
Xiaoqian Liu, Kang Lu, Lili Feng, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2013) Vol. 55, Iss. 2, pp. 405-414
Closed Access | Times Cited: 40
Increased regulatory T cells in acute lymphoblastic leukemia patients
Siti-Zuleha Idris, Norfarazieda Hassan, Le-Jie Lee, et al.
Hematology (2015) Vol. 20, Iss. 9, pp. 523-529
Open Access | Times Cited: 38
Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy
Juan C. Gomez-Gelvez, Mohamed E. Salama, Sherrie L. Perkins, et al.
American Journal of Clinical Pathology (2016) Vol. 145, Iss. 4, pp. 514-523
Open Access | Times Cited: 37
The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis
Bogusław Nedoszytko, Magdalena Lange, Małgorzata Sokołowska‐Wojdyło, et al.
Advances in Dermatology and Allergology (2017) Vol. 5, pp. 405-417
Open Access | Times Cited: 37
Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies
Virginia Camacho, Valeriya Kuznetsova, Robert S. Welner
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
Kamira Maharaj, Angimar Uriepero, Eva Sahakian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
High Levels of Regulatory T Cells in Blood Are a Poor Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma
Chen Chang, Shang‐Yin Wu, Yu-Wei Kang, et al.
American Journal of Clinical Pathology (2015) Vol. 144, Iss. 6, pp. 935-944
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top